Navigation Links
Clinical Research Staffing Firm ASG Acquires CRO Ockham Development Group
Date:3/2/2009

Merger provides additional value to clients, shareholders and employees

CARY, N.C., March 2 /PRNewswire/ -- ASG, Inc. - a high-quality functional outsourcing and specialty staffing services group based in Cary, North Carolina - has acquired neighboring Ockham Development Group, Inc., a full-service contract research organization.

The acquisition - completed in early February for an undisclosed amount of stock - enables ASG to expand the breadth and value of services it provides clients needing to outsource clinical research trials; it also equips its clients in the pharmaceutical industry with a robust package of functional outsourcing and staffing services as well as a new opportunity to outsource an entire clinical trial.

"The addition of the Ockham team and its services helps accelerate our goal of becoming the company of choice for those wishing to outsource or augment staffing of a clinical trial," said ASG President and CEO James Baker. "We now have the breadth of services that allows clients to one-stop shop if they so desire."

In completing the acquisition, ASG is fulfilling a portion of its global growth strategy that will allow the firm to provide solutions that best meet the needs of existing and potential clients. At the same time, the acquisition will make it possible for Ockham - which will continue to be independently branded - to serve a wider and larger client base.

"The ASG platform will make it possible for Ockham to scale its operations and extend its client reach into a true global presence," said Ockham CEO, Dr. Josh Baker (unrelated), who now leads the company's clinical research organization operations. "This is a unique opportunity to combine with a stable industry leader and quickly build market value."

About ASG:

ASG provides high-quality functional outsourcing and specialty staffing services to CROs, pharmaceutical, biotech and medical device companies that require clinical operations, GCP, GLP or GMP auditing, data management, statistical programming, biostatistics and medical writing solutions. Strategically organized to meet the demands of the marketplace, ASG provides flexible solutions that satisfy client needs through highly experienced recruiting and dedicated functional support teams located throughout the world. http://www.asg-inc.com

About Ockham Development Group:

Ockham Development Group Inc. is a privately held contract research organization headquartered in Cary, North Carolina. Staffed by veteran industry professionals with a track record of proven results, it is centrally located near the university-technology-biotech / pharmaceutical sciences nexus known internationally as Research Triangle Park (RTP).


'/>"/>
SOURCE ASG, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate Directed Against the Fusion (F) Protein
2. Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain
3. Implicit Licenses Clinical Stage Antibody Program From Lilly
4. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
5. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
6. Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
7. M2S Expert gives address "Applying the Principles of Six Sigma in the Imaging Core Lab" at Imaging for Clinical Trials conference
8. Histogen to Present Preliminary Hair Regrowth Clinical Results at Stem Cell Summit
9. AstraZeneca Implements Customized Cytel East(R) Software for More Accurate Trial Monitoring and Clinical Data Analysis
10. First Multiple Dose Clinical Trial of TorreyPines Therapeutics Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated
11. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... 2017  This year,s edition of the Inc. 5000 features a now-familiar ... solutions, has made the list for the third year in a row. ... private companies based on a set of quantitative metrics. In addition, BioPoint ... companies in the Bay State . ... Inc. 5000 ...
(Date:8/15/2017)... ... August 15, 2017 , ... ... that accelerate pharmaceutical and biotherapeutics development, announces the launch of the new ... needed to gain kinetic binding data for a wide range of molecules, including ...
(Date:8/15/2017)... NY (PRWEB) , ... August 15, 2017 , ... ... first time on Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and ... held February 7-9, 2018, at The Roosevelt Hotel in New York City. , “With ...
(Date:8/14/2017)... , ... August 14, 2017 , ... ... essential device-to-computer interconnect using USB or PCI Express, announced the release of SYZYGY™, ... is intended to satisfy the need for a compact, low cost, low pin-count, ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
Breaking Biology News(10 mins):